Sign in
4

Changes in Ownership

Protagenic Therapeutics, Inc.new Filed Acc 0001493152-23-037136

Chief Financial Officer bought 8,000 shares at $0.81 ($6,480)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Arrow Alexander K. Chief Financial Officer 2023-10-12 Purchase +8,000 $0.81 $6,480 45,815 D
Open-market purchases · 8,000 sh · avg $0.81 · $6,480
Loading xslF345X05/ownership.xml…